1 Study Coverage 1.1 Transdermal Therapeutic Systems (TTS) Product Introduction 1.2 Market by Type 1.2.1 Global Transdermal Therapeutic Systems (TTS) Market Size Growth Rate by Type 1.2.2 Methyl Salicylate 1.2.3 Nitroglycerin 1.2.4 Fentanyl 1.2.5 Nicotine 1.2.6 Rivastigmine 1.2.7 Estradiol 1.2.8 Others 1.3 Market by Application 1.3.1 Global Transdermal Therapeutic Systems (TTS) Market Size Growth Rate by Application 1.3.2 OTC Channel 1.3.3 Retail Channel 1.3.4 E-Commerce Channel 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Transdermal Therapeutic Systems (TTS) Market Size, Estimates and Forecasts 2.1.1 Global Transdermal Therapeutic Systems (TTS) Revenue 2016-2027 2.1.2 Global Transdermal Therapeutic Systems (TTS) Sales 2016-2027 2.2 Global Transdermal Therapeutic Systems (TTS), Market Size by Region: 2016 VS 2021 VS 2027 2.3 Transdermal Therapeutic Systems (TTS) Historical Market Size by Region (2016-2021) 2.3.1 Global Transdermal Therapeutic Systems (TTS) Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Transdermal Therapeutic Systems (TTS) Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Transdermal Therapeutic Systems (TTS) Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Transdermal Therapeutic Systems (TTS) Sales Forecast by Region (2022-2027) 2.4.2 Global Transdermal Therapeutic Systems (TTS) Revenue Forecast by Region (2022-2027) 3 Global Transdermal Therapeutic Systems (TTS) Competitor Landscape by Players 3.1 Global Top Transdermal Therapeutic Systems (TTS) Manufacturers by Sales 3.1.1 Global Transdermal Therapeutic Systems (TTS) Sales by Manufacturer (2016-2021) 3.1.2 Global Transdermal Therapeutic Systems (TTS) Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Transdermal Therapeutic Systems (TTS) Manufacturers by Revenue 3.2.1 Key Transdermal Therapeutic Systems (TTS) Manufacturers Covered: Ranking by Revenue 3.2.2 Global Transdermal Therapeutic Systems (TTS) Revenue by Manufacturers (2016-2021) 3.2.3 Global Transdermal Therapeutic Systems (TTS) Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Transdermal Therapeutic Systems (TTS) Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Transdermal Therapeutic Systems (TTS) Revenue in 2020 3.2.6 Global Transdermal Therapeutic Systems (TTS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Transdermal Therapeutic Systems (TTS) Price by Manufacturers 3.4 Global Transdermal Therapeutic Systems (TTS) Manufacturing Base Distribution, Product Types 3.4.1 Transdermal Therapeutic Systems (TTS) Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Transdermal Therapeutic Systems (TTS) Product Type 3.4.3 Date of International Manufacturers Enter into Transdermal Therapeutic Systems (TTS) Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Transdermal Therapeutic Systems (TTS) Market Size by Type (2016-2021) 4.1.1 Global Transdermal Therapeutic Systems (TTS) Sales by Type (2016-2021) 4.1.2 Global Transdermal Therapeutic Systems (TTS) Revenue by Type (2016-2021) 4.1.3 Transdermal Therapeutic Systems (TTS) Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Transdermal Therapeutic Systems (TTS) Market Size Forecast by Type (2022-2027) 4.2.1 Global Transdermal Therapeutic Systems (TTS) Sales Forecast by Type (2022-2027) 4.2.2 Global Transdermal Therapeutic Systems (TTS) Revenue Forecast by Type (2022-2027) 4.2.3 Transdermal Therapeutic Systems (TTS) Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Transdermal Therapeutic Systems (TTS) Market Size by Application (2016-2021) 5.1.1 Global Transdermal Therapeutic Systems (TTS) Sales by Application (2016-2021) 5.1.2 Global Transdermal Therapeutic Systems (TTS) Revenue by Application (2016-2021) 5.1.3 Transdermal Therapeutic Systems (TTS) Price by Application (2016-2021) 5.2 Transdermal Therapeutic Systems (TTS) Market Size Forecast by Application (2022-2027) 5.2.1 Global Transdermal Therapeutic Systems (TTS) Sales Forecast by Application (2022-2027) 5.2.2 Global Transdermal Therapeutic Systems (TTS) Revenue Forecast by Application (2022-2027) 5.2.3 Global Transdermal Therapeutic Systems (TTS) Price Forecast by Application (2022-2027) 6 United States by Players, Type and Application 6.1 United States Transdermal Therapeutic Systems (TTS) Market Size YoY Growth 2016-2027 6.1.1 United States Transdermal Therapeutic Systems (TTS) Sales YoY Growth 2016-2027 6.1.2 United States Transdermal Therapeutic Systems (TTS) Revenue YoY Growth 2016-2027 6.1.3 United States Transdermal Therapeutic Systems (TTS) Market Share in Global Market 2016-2027 6.2 United States Transdermal Therapeutic Systems (TTS) Market Size by Players (International and Local Players) 6.2.1 United States Top Transdermal Therapeutic Systems (TTS) Players by Sales (2016-2021) 6.2.2 United States Top Transdermal Therapeutic Systems (TTS) Players by Revenue (2016-2021) 6.3 United States Transdermal Therapeutic Systems (TTS) Historic Market Review by Type (2016-2021) 6.3.1 United States Transdermal Therapeutic Systems (TTS) Sales Market Share by Type (2016-2021) 6.3.2 United States Transdermal Therapeutic Systems (TTS) Revenue Market Share by Type (2016-2021) 6.3.3 United States Transdermal Therapeutic Systems (TTS) Price by Type (2016-2021) 6.4 United States Transdermal Therapeutic Systems (TTS) Market Estimates and Forecasts by Type (2022-2027) 6.4.1 United States Transdermal Therapeutic Systems (TTS) Sales Forecast by Type (2022-2027) 6.4.2 United States Transdermal Therapeutic Systems (TTS) Revenue Forecast by Type (2022-2027) 6.4.3 United States Transdermal Therapeutic Systems (TTS) Price Forecast by Type (2022-2027) 6.5 United States Transdermal Therapeutic Systems (TTS) Historic Market Review by Application (2016-2021) 6.5.1 United States Transdermal Therapeutic Systems (TTS) Sales Market Share by Application (2016-2021) 6.5.2 United States Transdermal Therapeutic Systems (TTS) Revenue Market Share by Application (2016-2021) 6.5.3 United States Transdermal Therapeutic Systems (TTS) Price by Application (2016-2021) 6.6 United States Transdermal Therapeutic Systems (TTS) Market Estimates and Forecasts by Application (2022-2027) 6.6.1 United States Transdermal Therapeutic Systems (TTS) Sales Forecast by Application (2022-2027) 6.6.2 United States Transdermal Therapeutic Systems (TTS) Revenue Forecast by Application (2022-2027) 6.6.3 United States Transdermal Therapeutic Systems (TTS) Price Forecast by Application (2022-2027) 7 North America 7.1 North America Transdermal Therapeutic Systems (TTS) Market Size YoY Growth 2016-2027 7.2 North America Transdermal Therapeutic Systems (TTS) Market Facts & Figures by Country 7.2.1 North America Transdermal Therapeutic Systems (TTS) Sales by Country (2016-2021) 7.2.2 North America Transdermal Therapeutic Systems (TTS) Revenue by Country (2016-2021) 7.2.3 United States 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Transdermal Therapeutic Systems (TTS) Market Size YoY Growth 2016-2027 8.2 Asia Pacific Transdermal Therapeutic Systems (TTS) Market Facts & Figures by Region 8.2.1 Asia Pacific Transdermal Therapeutic Systems (TTS) Sales by Region (2016-2021) 8.2.2 Asia Pacific Transdermal Therapeutic Systems (TTS) Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 9 Europe 9.1 Europe Transdermal Therapeutic Systems (TTS) Market Size YoY Growth 2016-2027 9.2 Europe Transdermal Therapeutic Systems (TTS) Market Facts & Figures by Country 9.2.1 Europe Transdermal Therapeutic Systems (TTS) Sales by Country (2016-2021) 9.2.2 Europe Transdermal Therapeutic Systems (TTS) Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Transdermal Therapeutic Systems (TTS) Market Size YoY Growth 2016-2027 10.2 Latin America Transdermal Therapeutic Systems (TTS) Market Facts & Figures by Country 10.2.1 Latin America Transdermal Therapeutic Systems (TTS) Sales by Country (2016-2021) 10.2.2 Latin America Transdermal Therapeutic Systems (TTS) Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Transdermal Therapeutic Systems (TTS) Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Transdermal Therapeutic Systems (TTS) Market Facts & Figures by Country 11.2.1 Middle East and Africa Transdermal Therapeutic Systems (TTS) Sales by Country (2016-2021) 11.2.2 Middle East and Africa Transdermal Therapeutic Systems (TTS) Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 Hisamitsu 12.1.1 Hisamitsu Corporation Information 12.1.2 Hisamitsu Description and Business Overview 12.1.3 Hisamitsu Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Hisamitsu Transdermal Therapeutic Systems (TTS) Products Offered 12.1.5 Hisamitsu Recent Development 12.2 Mylan 12.2.1 Mylan Corporation Information 12.2.2 Mylan Description and Business Overview 12.2.3 Mylan Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Mylan Transdermal Therapeutic Systems (TTS) Products Offered 12.2.5 Mylan Recent Development 12.3 GSK 12.3.1 GSK Corporation Information 12.3.2 GSK Description and Business Overview 12.3.3 GSK Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021) 12.3.4 GSK Transdermal Therapeutic Systems (TTS) Products Offered 12.3.5 GSK Recent Development 12.4 Novartis 12.4.1 Novartis Corporation Information 12.4.2 Novartis Description and Business Overview 12.4.3 Novartis Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Novartis Transdermal Therapeutic Systems (TTS) Products Offered 12.4.5 Novartis Recent Development 12.5 Teve (Actavis) 12.5.1 Teve (Actavis) Corporation Information 12.5.2 Teve (Actavis) Description and Business Overview 12.5.3 Teve (Actavis) Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Teve (Actavis) Transdermal Therapeutic Systems (TTS) Products Offered 12.5.5 Teve (Actavis) Recent Development 12.6 Nitto Denko 12.6.1 Nitto Denko Corporation Information 12.6.2 Nitto Denko Description and Business Overview 12.6.3 Nitto Denko Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Nitto Denko Transdermal Therapeutic Systems (TTS) Products Offered 12.6.5 Nitto Denko Recent Development 12.7 Johnson & Johnson 12.7.1 Johnson & Johnson Corporation Information 12.7.2 Johnson & Johnson Description and Business Overview 12.7.3 Johnson & Johnson Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Johnson & Johnson Transdermal Therapeutic Systems (TTS) Products Offered 12.7.5 Johnson & Johnson Recent Development 12.8 Lohmann 12.8.1 Lohmann Corporation Information 12.8.2 Lohmann Description and Business Overview 12.8.3 Lohmann Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Lohmann Transdermal Therapeutic Systems (TTS) Products Offered 12.8.5 Lohmann Recent Development 12.9 Teikoku Seiyaku 12.9.1 Teikoku Seiyaku Corporation Information 12.9.2 Teikoku Seiyaku Description and Business Overview 12.9.3 Teikoku Seiyaku Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Teikoku Seiyaku Transdermal Therapeutic Systems (TTS) Products Offered 12.9.5 Teikoku Seiyaku Recent Development 12.10 Pfizer 12.10.1 Pfizer Corporation Information 12.10.2 Pfizer Description and Business Overview 12.10.3 Pfizer Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Pfizer Transdermal Therapeutic Systems (TTS) Products Offered 12.10.5 Pfizer Recent Development 12.11 Hisamitsu 12.11.1 Hisamitsu Corporation Information 12.11.2 Hisamitsu Description and Business Overview 12.11.3 Hisamitsu Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Hisamitsu Transdermal Therapeutic Systems (TTS) Products Offered 12.11.5 Hisamitsu Recent Development 12.12 Lingrui 12.12.1 Lingrui Corporation Information 12.12.2 Lingrui Description and Business Overview 12.12.3 Lingrui Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Lingrui Products Offered 12.12.5 Lingrui Recent Development 12.13 Sanofi 12.13.1 Sanofi Corporation Information 12.13.2 Sanofi Description and Business Overview 12.13.3 Sanofi Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Sanofi Products Offered 12.13.5 Sanofi Recent Development 12.14 UCB Pharma 12.14.1 UCB Pharma Corporation Information 12.14.2 UCB Pharma Description and Business Overview 12.14.3 UCB Pharma Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021) 12.14.4 UCB Pharma Products Offered 12.14.5 UCB Pharma Recent Development 12.15 Dr. Reddy's Laboratories 12.15.1 Dr. Reddy's Laboratories Corporation Information 12.15.2 Dr. Reddy's Laboratories Description and Business Overview 12.15.3 Dr. Reddy's Laboratories Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021) 12.15.4 Dr. Reddy's Laboratories Products Offered 12.15.5 Dr. Reddy's Laboratories Recent Development 12.16 Qizheng 12.16.1 Qizheng Corporation Information 12.16.2 Qizheng Description and Business Overview 12.16.3 Qizheng Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021) 12.16.4 Qizheng Products Offered 12.16.5 Qizheng Recent Development 12.17 Endo 12.17.1 Endo Corporation Information 12.17.2 Endo Description and Business Overview 12.17.3 Endo Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021) 12.17.4 Endo Products Offered 12.17.5 Endo Recent Development 12.18 Mundipharma 12.18.1 Mundipharma Corporation Information 12.18.2 Mundipharma Description and Business Overview 12.18.3 Mundipharma Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021) 12.18.4 Mundipharma Products Offered 12.18.5 Mundipharma Recent Development 12.19 Huarun 999 12.19.1 Huarun 999 Corporation Information 12.19.2 Huarun 999 Description and Business Overview 12.19.3 Huarun 999 Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021) 12.19.4 Huarun 999 Products Offered 12.19.5 Huarun 999 Recent Development 12.20 Haw Par 12.20.1 Haw Par Corporation Information 12.20.2 Haw Par Description and Business Overview 12.20.3 Haw Par Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021) 12.20.4 Haw Par Products Offered 12.20.5 Haw Par Recent Development 12.21 Nichiban 12.21.1 Nichiban Corporation Information 12.21.2 Nichiban Description and Business Overview 12.21.3 Nichiban Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021) 12.21.4 Nichiban Products Offered 12.21.5 Nichiban Recent Development 12.22 Mentholatum Company 12.22.1 Mentholatum Company Corporation Information 12.22.2 Mentholatum Company Description and Business Overview 12.22.3 Mentholatum Company Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021) 12.22.4 Mentholatum Company Products Offered 12.22.5 Mentholatum Company Recent Development 12.23 Laboratoires Genevrier 12.23.1 Laboratoires Genevrier Corporation Information 12.23.2 Laboratoires Genevrier Description and Business Overview 12.23.3 Laboratoires Genevrier Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021) 12.23.4 Laboratoires Genevrier Products Offered 12.23.5 Laboratoires Genevrier Recent Development 12.24 Beijing Tide Pharmaceutical 12.24.1 Beijing Tide Pharmaceutical Corporation Information 12.24.2 Beijing Tide Pharmaceutical Description and Business Overview 12.24.3 Beijing Tide Pharmaceutical Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021) 12.24.4 Beijing Tide Pharmaceutical Products Offered 12.24.5 Beijing Tide Pharmaceutical Recent Development 12.25 Luye Pharma Group 12.25.1 Luye Pharma Group Corporation Information 12.25.2 Luye Pharma Group Description and Business Overview 12.25.3 Luye Pharma Group Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021) 12.25.4 Luye Pharma Group Products Offered 12.25.5 Luye Pharma Group Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Transdermal Therapeutic Systems (TTS) Industry Trends 13.2 Transdermal Therapeutic Systems (TTS) Market Drivers 13.3 Transdermal Therapeutic Systems (TTS) Market Challenges 13.4 Transdermal Therapeutic Systems (TTS) Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Transdermal Therapeutic Systems (TTS) Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Transdermal Therapeutic Systems (TTS) Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Methyl Salicylate Table 3. Major Manufacturers of Nitroglycerin Table 4. Major Manufacturers of Fentanyl Table 5. Major Manufacturers of Nicotine Table 6. Major Manufacturers of Rivastigmine Table 7. Major Manufacturers of Estradiol Table 8. Major Manufacturers of Others Table 9. Global Transdermal Therapeutic Systems (TTS) Market Size Growth Rate by Application (2021-2027) & (M Units) Table 10. Global Transdermal Therapeutic Systems (TTS) Market Size by Region (M Units) & (US$ Million), 2016 VS 2021 VS 2027 Table 11. Global Transdermal Therapeutic Systems (TTS) Sales by Regions (2016-2021) & (M Units) Table 12. Global Transdermal Therapeutic Systems (TTS) Sales Market Share by Regions (2016-2021) Table 13. Global Transdermal Therapeutic Systems (TTS) Revenue by Regions (2016-2021) & (US$ Million) Table 14. Global Transdermal Therapeutic Systems (TTS) Sales Forecast by Region (2022-2027) & (M Units) Table 15. Global Transdermal Therapeutic Systems (TTS) Sales Market Share Forecast by Region (2022-2027) Table 16. Global Transdermal Therapeutic Systems (TTS) Revenue Forecast by Region (2022-2027) & (US$ Million) Table 17. Global Transdermal Therapeutic Systems (TTS) Revenue Market Share Forecast by Region (2022-2027) Table 18. Global Transdermal Therapeutic Systems (TTS) Sales by Manufacturers (2016-2021) (M Units) Table 19. Global Transdermal Therapeutic Systems (TTS) Sales Share by Manufacturers (2016-2021) Table 20. Ranking of Global Top Transdermal Therapeutic Systems (TTS) Manufacturers by Revenue (US$ Million) in 2020 Table 21. Transdermal Therapeutic Systems (TTS) Revenue by Manufacturers (2016-2021) (US$ Million) Table 22. Transdermal Therapeutic Systems (TTS) Revenue Share by Manufacturers (2016-2021) Table 23. Global Transdermal Therapeutic Systems (TTS) Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 24. Global Transdermal Therapeutic Systems (TTS) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Therapeutic Systems (TTS) as of 2020) Table 25. Key Manufacturers Transdermal Therapeutic Systems (TTS) Price (2016-2021) (USD/K Units) Table 26. Transdermal Therapeutic Systems (TTS) Manufacturers Manufacturing Base Distribution and Headquarters Table 27. Manufacturers Transdermal Therapeutic Systems (TTS) Product Type Table 28. Date of International Manufacturers Enter into Transdermal Therapeutic Systems (TTS) Market Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans Table 30. Global Transdermal Therapeutic Systems (TTS) Sales by Type (2016-2021) (M Units) Table 31. Global Transdermal Therapeutic Systems (TTS) Sales Share by Type (2016-2021) Table 32. Global Transdermal Therapeutic Systems (TTS) Revenue by Type (2016-2021) (US$ Million) Table 33. Global Transdermal Therapeutic Systems (TTS) Revenue Share by Type (2016-2021) Table 34. Transdermal Therapeutic Systems (TTS) Average Selling Price (ASP) by Type (2016-2021) & (USD/K Units) Table 35. Global Transdermal Therapeutic Systems (TTS) Sales Forecast by Type (2022-2027) & (M Units) Table 36. Global Transdermal Therapeutic Systems (TTS) Sales Market Share Forecast by Type (2022-2027) Table 37. Global Transdermal Therapeutic Systems (TTS) Revenue Forecast V (2022-2027) & (US$ Million) Table 38. Global Transdermal Therapeutic Systems (TTS) Revenue Market Share Forecast by Type (2022-2027) Table 39. Global Transdermal Therapeutic Systems (TTS) Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/K Units) Table 40. Global Transdermal Therapeutic Systems (TTS) Sales by Application (2016-2021) (M Units) Table 41. Global Transdermal Therapeutic Systems (TTS) Sales Share by Application (2016-2021) Table 42. Global Transdermal Therapeutic Systems (TTS) Revenue by Application (2016-2021) (US$ Million) Table 43. Global Transdermal Therapeutic Systems (TTS) Revenue Share by Application (2016-2021) Table 44. Transdermal Therapeutic Systems (TTS) Average Selling Price (ASP) by Application (2016-2021) & (USD/K Units) Table 45. Global Transdermal Therapeutic Systems (TTS) Sales Forecast by Application (2022-2027) & (M Units) Table 46. Global Transdermal Therapeutic Systems (TTS) Sales Market Share Forecast by Application (2022-2027) Table 47. Global Transdermal Therapeutic Systems (TTS) Revenue Forecast by Application (2022-2027) & (US$ Million) Table 48. Global Transdermal Therapeutic Systems (TTS) Revenue Market Share Forecast by Application (2022-2027) Table 49. Global Transdermal Therapeutic Systems (TTS) Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/K Units) Table 50. United States Transdermal Therapeutic Systems (TTS) Sales (M Units) of Key Companies (2016-2021) Table 51. United States Transdermal Therapeutic Systems (TTS) Sales Share by Company (2016-2021) Table 52. United States Transdermal Therapeutic Systems (TTS) Revenue (US$ Million) by Company (2016-2021) Table 53. United States Transdermal Therapeutic Systems (TTS) Revenue Share by Company (2016-2021) Table 54. United States Transdermal Therapeutic Systems (TTS) Sales (M Units) by Type (2016-2021) Table 55. United States Transdermal Therapeutic Systems (TTS) Sales Share by Type (2016-2021) Table 56. United States Transdermal Therapeutic Systems (TTS) Revenue (US$ Million) Market Share by Type (2016-2021) Table 57. United States Transdermal Therapeutic Systems (TTS) Price (USD/K Units) by Type (2016-2021) Table 58. United States Transdermal Therapeutic Systems (TTS) Sales (M Units) by Type (2022-2027) Table 59. United States Transdermal Therapeutic Systems (TTS) Sales Share by Type (2022-2027) Table 60. United States Transdermal Therapeutic Systems (TTS) Revenue (US$ Million) Market Share by Type (2022-2027) Table 61. United States Transdermal Therapeutic Systems (TTS) Revenue Share by Type (2022-2027) Table 62. United States Transdermal Therapeutic Systems (TTS) Price (USD/K Units) by Type (2022-2027) Table 63. United States Transdermal Therapeutic Systems (TTS) Sales (M Units) by Application (2016-2021) Table 64. United States Transdermal Therapeutic Systems (TTS) Sales Share by Application (2016-2021) Table 65. United States Transdermal Therapeutic Systems (TTS) Revenue (US$ Million) Market Share by Application (2016-2021) Table 66. United States Transdermal Therapeutic Systems (TTS) Price (USD/K Units) by Application (2016-2021) Table 67. United States Transdermal Therapeutic Systems (TTS) Sales (M Units) by Application (2022-2027) Table 68. United States Transdermal Therapeutic Systems (TTS) Sales Share by Application (2022-2027) Table 69. United States Transdermal Therapeutic Systems (TTS) Revenue (US$ Million) Market Share by Application (2022-2027) Table 70. United States Transdermal Therapeutic Systems (TTS) Revenue Share by Application (2022-2027) Table 71. United States Transdermal Therapeutic Systems (TTS) Price (USD/K Units) by Application (2022-2027) Table 72. North America Transdermal Therapeutic Systems (TTS) Sales by Country (2016-2021) & (M Units) Table 73. North America Transdermal Therapeutic Systems (TTS) Sales Market Share by Country (2016-2021) Table 74. North America Transdermal Therapeutic Systems (TTS) Revenue by Country (2016-2021) & (US$ Million) Table 75. North America Transdermal Therapeutic Systems (TTS) Revenue Market Share by Country (2016-2021) Table 76. Asia Pacific Transdermal Therapeutic Systems (TTS) Sales by Region (2016-2021) & (M Units) Table 77. Asia Pacific Transdermal Therapeutic Systems (TTS) Sales Market Share by Region (2016-2021) Table 78. Asia Pacific Transdermal Therapeutic Systems (TTS) Revenue by Region (2016-2021) & (US$ Million) Table 79. Asia Pacific Transdermal Therapeutic Systems (TTS) Revenue Market Share by Region (2016-2021) Table 80. Europe Transdermal Therapeutic Systems (TTS) Sales by Country (2016-2021) & (M Units) Table 81. Europe Transdermal Therapeutic Systems (TTS) Sales Market Share by Country (2016-2021) Table 82. Europe Transdermal Therapeutic Systems (TTS) Revenue by Country (2016-2021) & (US$ Million) Table 83. Europe Transdermal Therapeutic Systems (TTS) Revenue Market Share by Country (2016-2021) Table 84. Latin America Transdermal Therapeutic Systems (TTS) Sales by Country (2016-2021) & (M Units) Table 85. Latin America Transdermal Therapeutic Systems (TTS) Sales Market Share by Country (2016-2021) Table 86. Latin Americaa Transdermal Therapeutic Systems (TTS) Revenue by Country (2016-2021) & (US$ Million) Table 87. Latin America Transdermal Therapeutic Systems (TTS) Revenue Market Share by Country (2016-2021) Table 88. Middle East and Africa Transdermal Therapeutic Systems (TTS) Sales by Country (2016-2021) & (M Units) Table 89. Middle East and Africa Transdermal Therapeutic Systems (TTS) Sales Market Share by Country (2016-2021) Table 90. Middle East and Africa Transdermal Therapeutic Systems (TTS) Revenue by Country (2016-2021) & (US$ Million) Table 91. Middle East and Africa Transdermal Therapeutic Systems (TTS) Revenue Market Share by Country (2016-2021) Table 92. Hisamitsu Corporation Information Table 93. Hisamitsu Description and Business Overview Table 94. Hisamitsu Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021) Table 95. Hisamitsu Transdermal Therapeutic Systems (TTS) Product Table 96. Hisamitsu Recent Development Table 97. Mylan Corporation Information Table 98. Mylan Description and Business Overview Table 99. Mylan Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021) Table 100. Mylan Product Table 101. Mylan Recent Development Table 102. GSK Corporation Information Table 103. GSK Description and Business Overview Table 104. GSK Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021) Table 105. GSK Product Table 106. GSK Recent Development Table 107. Novartis Corporation Information Table 108. Novartis Description and Business Overview Table 109. Novartis Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021) Table 110. Novartis Product Table 111. Novartis Recent Development Table 112. Teve (Actavis) Corporation Information Table 113. Teve (Actavis) Description and Business Overview Table 114. Teve (Actavis) Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021) Table 115. Teve (Actavis) Product Table 116. Teve (Actavis) Recent Development Table 117. Nitto Denko Corporation Information Table 118. Nitto Denko Description and Business Overview Table 119. Nitto Denko Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021) Table 120. Nitto Denko Product Table 121. Nitto Denko Recent Development Table 122. Johnson & Johnson Corporation Information Table 123. Johnson & Johnson Description and Business Overview Table 124. Johnson & Johnson Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021) Table 125. Johnson & Johnson Product Table 126. Johnson & Johnson Recent Development Table 127. Lohmann Corporation Information Table 128. Lohmann Description and Business Overview Table 129. Lohmann Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021) Table 130. Lohmann Product Table 131. Lohmann Recent Development Table 132. Teikoku Seiyaku Corporation Information Table 133. Teikoku Seiyaku Description and Business Overview Table 134. Teikoku Seiyaku Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021) Table 135. Teikoku Seiyaku Product Table 136. Teikoku Seiyaku Recent Development Table 137. Pfizer Corporation Information Table 138. Pfizer Description and Business Overview Table 139. Pfizer Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021) Table 140. Pfizer Product Table 141. Pfizer Recent Development Table 142. Bayer Corporation Information Table 143. Bayer Description and Business Overview Table 144. Bayer Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021) Table 145. Bayer Product Table 146. Bayer Recent Development Table 147. Lingrui Corporation Information Table 148. Lingrui Description and Business Overview Table 149. Lingrui Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021) Table 150. Lingrui Product Table 151. Lingrui Recent Development Table 152. Sanofi Corporation Information Table 153. Sanofi Description and Business Overview Table 154. Sanofi Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021) Table 155. Sanofi Product Table 156. Sanofi Recent Development Table 157. UCB Pharma Corporation Information Table 158. UCB Pharma Description and Business Overview Table 159. UCB Pharma Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021) Table 160. UCB Pharma Product Table 161. UCB Pharma Recent Development Table 162. Dr. Reddy's Laboratories Corporation Information Table 163. Dr. Reddy's Laboratories Description and Business Overview Table 164. Dr. Reddy's Laboratories Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021) Table 165. Dr. Reddy's Laboratories Product Table 166. Dr. Reddy's Laboratories Recent Development Table 167. Qizheng Corporation Information Table 168. Qizheng Description and Business Overview Table 169. Qizheng Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021) Table 170. Qizheng Product Table 171. Qizheng Recent Development Table 172. Endo Corporation Information Table 173. Endo Description and Business Overview Table 174. Endo Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021) Table 175. Endo Product Table 176. Endo Recent Development Table 177. Mundipharma Corporation Information Table 178. Mundipharma Description and Business Overview Table 179. Mundipharma Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021) Table 180. Mundipharma Product Table 181. Mundipharma Recent Development Table 182. Huarun 999 Corporation Information Table 183. Huarun 999 Description and Business Overview Table 184. Huarun 999 Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021) Table 185. Huarun 999 Product Table 186. Huarun 999 Recent Development Table 187. Haw Par Corporation Information Table 188. Haw Par Description and Business Overview Table 189. Haw Par Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021) Table 190. Haw Par Product Table 191. Haw Par Recent Development Table 192. Nichiban Corporation Information Table 193. Nichiban Description and Business Overview Table 194. Nichiban Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021) Table 195. Nichiban Product Table 196. Nichiban Recent Development Table 197. Mentholatum Company Corporation Information Table 198. Mentholatum Company Description and Business Overview Table 199. Mentholatum Company Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021) Table 200. Mentholatum Company Product Table 201. Mentholatum Company Recent Development Table 202. Laboratoires Genevrier Corporation Information Table 203. Laboratoires Genevrier Description and Business Overview Table 204. Laboratoires Genevrier Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021) Table 205. Laboratoires Genevrier Product Table 206. Laboratoires Genevrier Recent Development Table 207. Beijing Tide Pharmaceutical Corporation Information Table 208. Beijing Tide Pharmaceutical Description and Business Overview Table 209. Beijing Tide Pharmaceutical Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021) Table 210. Beijing Tide Pharmaceutical Product Table 211. Beijing Tide Pharmaceutical Recent Development Table 212. Luye Pharma Group Corporation Information Table 213. Luye Pharma Group Description and Business Overview Table 214. Luye Pharma Group Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021) Table 215. Luye Pharma Group Product Table 216. Luye Pharma Group Recent Development Table 217. Transdermal Therapeutic Systems (TTS) Market Trends Table 218. Transdermal Therapeutic Systems (TTS) Market Drivers Table 219. Transdermal Therapeutic Systems (TTS) Market Challenges Table 220. Transdermal Therapeutic Systems (TTS) Market Restraints Table 221. Transdermal Therapeutic Systems (TTS) Customers List Table 222. Transdermal Therapeutic Systems (TTS) Distributors List Table 223. Research Programs/Design for This Report Table 224. Key Data Information from Secondary Sources Table 225. Key Data Information from Primary Sources List of Figures Figure 1. Transdermal Therapeutic Systems (TTS) Product Picture Figure 2. Global Transdermal Therapeutic Systems (TTS) Sales Market Share by Type in 2020 & 2027 Figure 3. Methyl Salicylate Product Picture Figure 4. Nitroglycerin Product Picture Figure 5. Fentanyl Product Picture Figure 6. Nicotine Product Picture Figure 7. Rivastigmine Product Picture Figure 8. Estradiol Product Picture Figure 9. Others Product Picture Figure 10. Global Transdermal Therapeutic Systems (TTS) Sales Market Share by Application in 2020 & 2027 Figure 11. OTC Channel Figure 12. Retail Channel Figure 13. E-Commerce Channel Figure 14. Transdermal Therapeutic Systems (TTS) Report Years Considered Figure 15. Global Transdermal Therapeutic Systems (TTS) Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 16. Global Transdermal Therapeutic Systems (TTS) Market Size 2016-2027 (US$ Million) Figure 17. Global Transdermal Therapeutic Systems (TTS) Sales 2016-2027 (M Units) Figure 18. Global Transdermal Therapeutic Systems (TTS) Market Size Market Share by Region: 2021 Versus 2027 Figure 19. Global Transdermal Therapeutic Systems (TTS) Sales Market Share by Region (2016-2021) Figure 20. Global Transdermal Therapeutic Systems (TTS) Sales Market Share by Region in 2020 Figure 21. Global Transdermal Therapeutic Systems (TTS) Revenue Market Share by Region (2016-2021) Figure 22. Global Transdermal Therapeutic Systems (TTS) Revenue Market Share by Region in 2020 Figure 23. Global Transdermal Therapeutic Systems (TTS) Sales Share by Manufacturer in 2020 Figure 24. The Top 10 and 5 Players Market Share by Transdermal Therapeutic Systems (TTS) Revenue in 2020 Figure 25. Transdermal Therapeutic Systems (TTS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 26. Global Transdermal Therapeutic Systems (TTS) Sales Market Share by Type (2016-2021) Figure 27. Global Transdermal Therapeutic Systems (TTS) Sales Market Share by Type in 2020 Figure 28. Global Transdermal Therapeutic Systems (TTS) Revenue Market Share by Type (2016-2021) Figure 29. Global Transdermal Therapeutic Systems (TTS) Revenue Market Share by Type in 2020 Figure 30. Global Transdermal Therapeutic Systems (TTS) Sales Market Share by Application (2016-2021) Figure 31. Global Transdermal Therapeutic Systems (TTS) Sales Market Share by Application in 2020 Figure 32. Global Transdermal Therapeutic Systems (TTS) Revenue Market Share by Application (2016-2021) Figure 33. Global Transdermal Therapeutic Systems (TTS) Revenue Market Share by Application in 2020 Figure 34. United States Transdermal Therapeutic Systems (TTS) Sales Growth Rate 2016-2027 (M Units) Figure 35. United States Transdermal Therapeutic Systems (TTS) Revenue Growth Rate 2016-2027 (US$ Million) Figure 36. United States Transdermal Therapeutic Systems (TTS) Market Share in Global Market 2016-2027 Figure 37. United States 5 and 10 Largest Transdermal Therapeutic Systems (TTS) Players Market Share by Revenue in Transdermal Therapeutic Systems (TTS) in 2020 Figure 38. United States Transdermal Therapeutic Systems (TTS) Revenue Share by Type (2016-2021) Figure 39. United States Transdermal Therapeutic Systems (TTS) Revenue Growth Rate by Type in 2016 & 2020 Figure 40. United States Transdermal Therapeutic Systems (TTS) Revenue Share by Application (2016-2021) Figure 41. United States Transdermal Therapeutic Systems (TTS) Revenue Growth Rate by Application in 2016 & 2020 Figure 42. North America Transdermal Therapeutic Systems (TTS) Sales Growth Rate 2016-2021 (M Units) Figure 43. North America Transdermal Therapeutic Systems (TTS) Revenue Growth Rate 2016-2021 (US$ Million) Figure 44. North America Transdermal Therapeutic Systems (TTS) Sales Market Share by Country in 2020 Figure 45. North America Transdermal Therapeutic Systems (TTS) Revenue Market Share by Country in 2020 Figure 46. United States Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units) Figure 47. United States Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Canada Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units) Figure 49. Canada Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million) Figure 50. Europe Transdermal Therapeutic Systems (TTS) Sales Growth Rate 2016-2021 (M Units) Figure 51. Europe Transdermal Therapeutic Systems (TTS) Revenue Growth Rate 2016-2021 (US$ Million) Figure 52. Europe Transdermal Therapeutic Systems (TTS) Sales Market Share by Country in 2020 Figure 53. Europe Transdermal Therapeutic Systems (TTS) Revenue Market Share by Country in 2020 Figure 54. Germany Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units) Figure 55. Germany Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million) Figure 56. France Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units) Figure 57. France Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million) Figure 58. U.K. Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units) Figure 59. U.K. Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million) Figure 60. Italy Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units) Figure 61. Italy Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million) Figure 62. Russia Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units) Figure 63. Russia Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million) Figure 64. Asia Pacific Transdermal Therapeutic Systems (TTS) Sales Growth Rate 2016-2021 (M Units) Figure 65. Asia Pacific Transdermal Therapeutic Systems (TTS) Revenue Growth Rate 2016-2021 (US$ Million) Figure 66. Asia Pacific Transdermal Therapeutic Systems (TTS) Sales Market Share by Region in 2020 Figure 67. Asia Pacific Transdermal Therapeutic Systems (TTS) Revenue Market Share by Region in 2020 Figure 68. China Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units) Figure 69. China Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million) Figure 70. Japan Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units) Figure 71. Japan Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million) Figure 72. South Korea Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units) Figure 73. South Korea Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million) Figure 74. India Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units) Figure 75. India Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million) Figure 76. Australia Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units) Figure 77. Australia Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million) Figure 78. China Taiwan Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units) Figure 79. China Taiwan Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million) Figure 80. Indonesia Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units) Figure 81. Indonesia Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million) Figure 82. Thailand Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units) Figure 83. Thailand Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million) Figure 84. Malaysia Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units) Figure 85. Malaysia Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million) Figure 86. Latin America Transdermal Therapeutic Systems (TTS) Sales Growth Rate 2016-2021 (M Units) Figure 87. Latin America Transdermal Therapeutic Systems (TTS) Revenue Growth Rate 2016-2021 (US$ Million) Figure 88. Latin America Transdermal Therapeutic Systems (TTS) Sales Market Share by Country in 2020 Figure 89. Latin America Transdermal Therapeutic Systems (TTS) Revenue Market Share by Country in 2020 Figure 90. Mexico Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units) Figure 91. Mexico Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million) Figure 92. Brazil Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units) Figure 93. Brazil Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million) Figure 94. Argentina Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units) Figure 95. Argentina Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million) Figure 96. Middle East and Africa Transdermal Therapeutic Systems (TTS) Sales Growth Rate 2016-2021 (M Units) Figure 97. Middle East and Africa Transdermal Therapeutic Systems (TTS) Revenue Growth Rate 2016-2021 (US$ Million) Figure 98. Middle East and Africa Transdermal Therapeutic Systems (TTS) Sales Market Share by Country in 2020 Figure 99. Middle East and Africa Transdermal Therapeutic Systems (TTS) Revenue Market Share by Country in 2020 Figure 100. Turkey Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units) Figure 101. Turkey Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million) Figure 102. Saudi Arabia Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units) Figure 103. Saudi Arabia Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million) Figure 104. UAE Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units) Figure 105. UAE Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million) Figure 106. Transdermal Therapeutic Systems (TTS) Value Chain Figure 107. Channels of Distribution Figure 108. Distributors Profiles Figure 109. Bottom-up and Top-down Approaches for This Report Figure 110. Data Triangulation Figure 111. Key Executives Interviewed

Hisamitsu Mylan GSK Novartis Teve (Actavis) Nitto Denko Johnson & Johnson Lohmann Teikoku Seiyaku Pfizer Bayer Lingrui Sanofi UCB Pharma Dr. Reddy's Laboratories Qizheng Endo Mundipharma Huarun 999 Haw Par Nichiban Mentholatum Company Laboratoires Genevrier Beijing Tide Pharmaceutical Luye Pharma Group